PTC Therapeutics (NASDAQ:PTCT) VP Mark Elliott Boulding Sells 192 Shares of Company Stock
MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) VP Mark Boulding sold 192 shares of the firm's stock in a transaction on Friday, October 9th. The stock was sold at an average price of $64.26, for a total value of $12,337.92. Following the transaction, the vice president owned 105,272 shares in the company, valued at $6,764,778.72. This trade represents a 0.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ:PTCT